By Admin at 23 Oct 2017

At a meeting of the American Association of Cancer Research in Boston, Dr. Steven Rosenberg, researcher and chief of surgery at the National Cancer Institute (NCI) reported on the first patient with metastatic breast cancer to be essentially cured following immunotherapy treatment.

By Admin at 11 Nov 2016

Cryoablation, or deep freezing, may represent the wave of the future for treating certain types of breast cancer. The procedure requires no hospitalization, takes less than 30 minutes and requires no recovery time — patients walk out of treatment with only a Band-Aid to show for it.

By Admin at 7 Nov 2016

A genetic test known as the 21-gene recurrence score assay (RS) measures the activity of genes that control cell growth and more. A high score on the test indicates a woman has a high risk of cancer recurrence and chemotherapy is recommended. A low score suggests chemotherapy can safely be skipped.

By Admin at 13 Oct 2016

About 5 percent of breast cancer patients develop cancer in the other breast (contralateral breast cancer) within 10 years of their initial diagnosis. Drugs including tamoxifen and aromatase inhibitors are often prescribed to patients to reduce this risk, but researchers from the U.S. National Institutes of Health wanted to find out just how beneficial the drugs were in real-life settings.

By Admin at 26 Aug 2016

Aromatase inhibitors are often used to shrink breast tumors prior to surgery, but new research suggests it may be wise to reevaluate the tumor again just prior to surgery to monitor its changes and decide if a new course of treatment would be appropriate.